Public deck

Abbott (ABT): the diabetes-device machine now carrying a $20.6B cancer-diagnostics bet

Abbott's Medical Devices engine, led by diabetes care, is doing the heavy lifting while Nutrition weakens and the Exact Sciences acquisition adds cancer-diagnostics upside, debt, and integration risk.